Abstracts Archive - Page 1421 of 2425 - ACR Meeting Abstracts

Abstract Number: 33 • 2016 ACR/ARHP Annual Meeting
Prevalence of Growth Hormone Deficiency in Fibromyalgia Patients
Thomas Romano, Private Practice, Martins Ferry, OH
Background/Purpose: Low levels of Insulin-dependent growth factor 1 (IGF-1) have been described in Fibromyalgia (FM) patients, suggesting that they have adult growth hormone (GH) deficiency.…
Abstract Number: 34 • 2016 ACR/ARHP Annual Meeting
Differential Analgesic Pharmacological Effects on Brain Connectivity in Fibromyalgia (FM)
Eric Ichesco¹, Johnson Hampson², Lynne Pauer³, Andrew Clair⁴, Tobias Schmidt-Wilcke⁵, David Williams⁶, Daniel J. Clauw⁶ and Richard E. Harris⁷, ¹Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, ²Anesthesiology, University of Michigan, Ann Arbor, MI, ³Pfizer Inc, New London, CT, ⁴Pfizer, New York, NY, ⁵Bergmannsheil, Bochum, Germany, ⁶Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI, ⁷Anesthesiology, U. Michigan, Ann Arbor, MI
Background/Purpose: Brain imaging techniques including functional magnetic resonance imaging (fMRI) may be useful in probing the mechanisms of action of centrally acting analgesics. Previously we…
Abstract Number: 35 • 2016 ACR/ARHP Annual Meeting
WITHDRAWN
Abstract Number: 36 • 2016 ACR/ARHP Annual Meeting
Dysautonomia and Osteoporosis in 2300 Ehlers-Danlos Hypermobile Patients, As Defined By the Brighton Criteria
Jaime F. Bravo, Medical School, Universidad de Chile, santiago, Chile
Dysautonomia and Osteoporosis in 2300 EDS type III patients, as defined by the Brighton criteria Background/Purpose: To highlight the high frequency of Dysautonomia (Dys)…
Abstract Number: 37 • 2016 ACR/ARHP Annual Meeting
Association Between Fibromyalgia and Bone Mineral Density: A Systematic Review and Meta-Analysis
Sikarin Upala¹ and Anawin Sanguankeo², ¹Internal Medicine, Bassett Medical Center, Cooperstown, NY, ²Bassett Medical Center, Cooperstown, NY
Background/Purpose: Previous studies have shown that fibromyalgia syndrome (FMS) is associated with low level of physical activity and exercise, which may lead to an increased…
Abstract Number: 38 • 2016 ACR/ARHP Annual Meeting
How Does Thiol/Disulphide Homeostasis Change in Fibromyalgia Patients?
Bilge Ekinci¹, Cemile Bicer², Pervin Baran³, Sema Haliloglu⁴, Hulya Uzkeser⁵ and Ayse Carlioglu⁶, ¹Physical Medicine and Rehabilitation, Erzurum Region Training and Research Hospital, Erzurum, Turkey, ²Biochemistry, Yildirim Beyazit University Medical Faculty, Ankara, Turkey, ³Biochemistry, Ataturk Training and Research Hospital, Ankara, Turkey, ⁴Physical Medicine and Rehabilitation, Maltepe Occupational Diseases Hospital, Istanbul, Turkey, ⁵Physical Medicine and Rehabilitation, Ataturk University Medical Faculty, erzuru, Turkey, ⁶Endocrinology, Erzurum Region Training and Research Hospital, Erzurum, Turkey
Background/Purpose: Our aim was to investigate the thiol/disulphide homeostasis, which has an important role in many cellular activities such as antioxidant protection, detoxification, cell growth…
Abstract Number: 39 • 2016 ACR/ARHP Annual Meeting
Effects of Pregabalin (Lyrica®) on Cerebrospinal Fluid Substance P in Human Subjects with Fibromyalgia Syndrome
Irwin Jon Russell¹, Joel E. Michalek² and Sorleen Trevino-Mendez³, ¹Affiliated with Arthritis & Osteoporosis Center of South Texas, Medical Director, Fibromyalgia Research and Consulting, San Antonio, Texas, San Antonio, TX, ²Professor, Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, San Antonio, TX, ³Medical Student, Texas Tech University School of Medicine, Lubbock, TX
Background/Purpose: Fibromyalgia Syndrome [FMS] is a common chronic pain disorder. Pregabalin (PGB) is one of three medications approved by the FDA for treatment of FMS.…
Abstract Number: 40 • 2016 ACR/ARHP Annual Meeting
Lateral Epicondylitis Treatment: Comparison of Bandage, Laser Therapy and Extra-Corporeal Shock Wave Therapy
Fatma Icyer¹, Hulya Uzkeser² and Saliha Karatay³, ¹Physical Medicine and Rehabilitation,, Ataturk University,Faculty of Medicine, Erzurum, Turkey, ²Physical Medicine and Rehabilitation, Ataturk University Medical Faculty, erzuru, Turkey, ³Physiotherapy and Rehabilitation,, Faculty of Health Sciences, Gazi University, Ankara, Turkey
Background/Purpose: Lateral epicondylitis is one of the most common conditions affecting elbow and characterized by a lesion of the common extensor tendon with or without…
Abstract Number: 41 • 2016 ACR/ARHP Annual Meeting
Human Papilloma Virus Vaccination, Fibromyalgia and Dysautonomia
Manuel Martínez-Lavín¹, Paola-Kinara Reyes-Loyola² and Laura-Aline Martinez-Martinez³, ¹Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ²Rheumatology, National Institute of Cardiology, Mexico, Mexico, ³Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, TX, Mexico
Background/Purpose: In a questionnaire-based case series, we described the clinical features of 45 patients who had the onset of a chronic illness soon after HPV…
Abstract Number: 42 • 2016 ACR/ARHP Annual Meeting
Small Fibre Neuropathy Biopsies (SFN) in Primary Fibromyalgia Revealed Predominant Association with Metabolic Syndrome (in addition to other known treatable causes of SFN) but No Clear Distinction Related to Biopsy Results
Euthalia Roussou¹, Johnathan Chan², Istvan Bodi³ and Aleksandar Radunivics², ¹Rheumatology, Dr, London, United Kingdom, ²Neurologist, London, United Kingdom, ³Department of Clinical Neuropathology, London, United Kingdom
Background/Purpose: To assess patients with primary fibromyalgia (pFM) for small fibre neuropathy (SFN) and to correlate biopsy results between groups and with known causes of…
Abstract Number: 43 • 2016 ACR/ARHP Annual Meeting
Comorbid Development of Fibromyalgia and Posttraumatic Stress Disorder after Exposure to a Combat Environment
Katrina Lawrence-Wolff¹, Jay B. Higgs², Douglas Williamson³, Stacey Young-McCaughan⁴, Jim Mintz⁴, Bernard Hildebrand¹, Antoinette Brundige⁴, Kevin Kelly⁵, Adam Borah⁵, Brett Litz⁶, Elizabeth Hembree⁷, Alan Peterson⁴ and STRONG STAR Consortium, ¹Rheumatology, San Antonio Military Medical Center, San Antonio, TX, ²Rheumatology, San Antonio Military Medical Center, Fort Sam Houston, TX, ³Duke Univeresity, Durham, NC, ⁴The University of Texas Health Science Center at San Antonio, San Antonio, TX, ⁵Carl R. Darnall Army Medical Center, Fort Hood, TX, ⁶VA Boston Healthcare System, Boston, MA, ⁷University of Pennsylvania, Philadelphia, PA
Background/Purpose: Traumatic experiences are postulated mediators of the development of Fibromyalgia Syndrome (FMS). The STRONG STAR Consortium study of PTSD provides a unique opportunity to…
Abstract Number: 44 • 2016 ACR/ARHP Annual Meeting
Ambroxol for Fibromyalgia. One-Group Pretest-Posttest Open Label Clinical Observation
Laura-Aline Martinez-Martinez¹, Luis-Fernando Perez², Gumaro Acosta², Lizbeth Becerril³, Pedro Rodriguez-Henriquez⁴, Omar-Eloy Muñoz-Monroy⁵, Luis H. Silveira⁶, Angelica Vargas Guerrero⁷ and Manuel Martínez-Lavín⁷, ¹Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, TX, Mexico, ²National Institute of Cardiology, Mexico, Mexico, ³Hospital Juarez, Mexico, Mexico, ⁴Rheumatology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, ⁵Hospital Militar, Mexico City, Mexico, ⁶Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City DF, Mexico, ⁷Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico
Background/Purpose: A consistent line of investigation proposes that fibromyalgia is a sympathetically maintained neuropathic pain syndrome. Moreover it has been suggested that dorsal root ganglia…
Abstract Number: 45 • 2016 ACR/ARHP Annual Meeting
Small Fiber Neuropathy in Rheumatology Clinics
Samy Metyas¹, Ramy Messiah², Tina Gettas², Christina Chen³ and Daniel Arkfeld⁴, ¹University of Southern California, Keck School of Medicine, Covina, CA, ²Research Associate, Covina Arthritis Clinic, covina, CA, ³Department of medicine, University of Southern California , Keck School of Medicine, Los Angeles, CA, ⁴Div of Rheumatology, Keck School of Medicine, University of Southern California-Los Angeles County Medical Center, Los Angeles, CA
Background/Purpose: , Small Fiber Neuropathy (SFN) is a condition prevalent in patients with rheumatic diseases, particularly Fibromyalgia. The presence of neuropathic pain with normal nerve…
Abstract Number: 46 • 2016 ACR/ARHP Annual Meeting
Novel Composite Responder Endpoints for Fibromyalgia Therapy Assessment
R Michael Gendreau¹, Lesley Arnold², Daniel J. Clauw³, Judith Gendreau⁴, Bruce Daugherty⁴ and Seth Lederman⁴, ¹Gendreau Consulting LLC, Poway, CA, ²University of Cincinnati, Cincinnati, OH, ³Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI, ⁴Tonix Pharmaceuticals, New York, NY
Background/Purpose: Novel composite responder definitions for fibromyalgia (FM) clinical trials have been proposed by the Outcome Measures in Rheumatology (OMERACT) FM subcommittee. These definitions which…
Abstract Number: 48 • 2016 ACR/ARHP Annual Meeting
Fibromyalgia Impact Is a Potential Mediator for the Associations of Self-Efficacy and Pain Catastrophizing with Physical Functioning in Persons with Fibromyalgia
Sun Yu¹, Lori Lyn Price², Jeffrey B. Driban¹, William F. Harvey¹ and Chenchen Wang¹, ¹Rheumatology, Tufts Medical Center, Boston, MA, ²Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
Background/Purpose: Fibromyalgia (FM) is a chronic multidimensional disorder that causes physical and psychological impairment, incurring significant healthcare costs. Self-efficacy and pain catastrophizing have been shown…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].